A review published in Genes & Diseases highlights how RNA molecules could help breast cancer cells respond more effectively to radiotherapy. Researchers at Mashhad University of Medical Sciences examine microRNAs and their inhibitors as potential tools for overcoming radiation resistance by restoring the mechanisms that trigger programmed cell death.
Radiotherapy damages cancer cells, but some tumors survive by disrupting apoptosis, the process through which damaged cells dismantle themselves. When this protective mechanism is weakened, cancer cells can continue growing despite treatment. The review explores whether adjusting microRNAs could make these cells more vulnerable to radiation.
MicroRNAs are short RNA molecules that regulate gene expression. Depending on their targets and biological context, they can promote or suppress tumor growth. AntagomiRs, also known as anti-miRNAs, are designed to inhibit particular microRNAs, offering another way to influence pathways controlling cell survival and treatment response.
The article brings together studies of breast cancer cells and animal models, distinguishing molecules linked to increased radiosensitivity from those associated with resistance. It also identifies microRNAs that promote apoptosis but have not yet been investigated alongside radiation, providing candidates for further research.
Among the examples discussed, increasing miR-200c enhanced radiation sensitivity and apoptotic cell death in breast cancer cell lines. Another molecule, miR-139-5p, affected DNA repair and defences against reactive oxygen species. Increasing its activity allowed radiation-induced damage to accumulate, helping trigger cancer cell death.
The review also highlights miR-22 and miR-205, which influence pathways involving survival signals and DNA repair. These findings illustrate how different microRNAs can converge on a common objective: weakening the mechanisms that allow tumor cells to withstand irradiation.
Conversely, miR-21 is associated with treatment resistance in breast cancer models. Studies reviewed found that blocking it with anti-miR-21 increased apoptosis and radiation sensitivity in cell lines. This supports investigating both replacement of protective microRNAs and inhibition of those that favour cancer cell survival.
The findings remain experimental and do not establish improved outcomes for patients receiving radiotherapy. Effects can vary between breast cancer subtypes and models, and molecules that enhance apoptosis alone cannot automatically be assumed to improve radiation response.
Further research must identify the most promising targets, confirm their effects in relevant tumor models, and establish safety and effectiveness before clinical application. Understanding interactions among RNA molecules and their gene targets will also be important.
Source:
Journal reference:
Najafi-Amiri, M., (2026) A comprehensive review on apoptotic miRNAs and antagomiRs in breast cancer: Enhancing radio sensitization. Genes & Diseases. DOI: 10.1016/j.gendis.2025.102024. https://www.sciencedirect.com/science/article/pii/S2352304225005136?via%3Dihub